SNY
Sanofi
B-
62.1 / 100 composite
AlphaQuality composite grade, weighted for stable earnings power businesses.
-
5yr Avg ROIC
7.0%
-
Operating Margin Trend
-0.91 pp/yr
-
5yr Avg ROE
9.1%
-
5yr Share-Count CAGR
-0.5%
-
5yr Revenue CAGR
4.6%
-
5yr EPS CAGR
-8.2%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
19.0%
-
5yr FCF/NI Conversion
1.22x
-
Net Debt / EBITDA
0.95x
-
Interest Coverage (EBIT/Int)
10.86x
-
Altman Z-Score
1.53
Stability
Weight: 15%
B-
67
-
EPS Volatility (σ/μ)
0.42
-
Negative-Revenue Years (5)
0/5
-
Piotroski F-Score
7
2 of 2 gurus held; 1 new buy; 1 added.
- Holders
- 2
+2
- Avg Δ position
-
—
- New buys
- 1
- Full exits
- 0